Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Evogene Ltd.

    NASDAQ: EVGN · Real-Time Price · USD
    1.62
    0.10 (6.58%)
    At close: Jun 17, 2025, 3:59 PM
    1.55
    -4.29%
    After-hours: Jun 17, 2025, 06:47 PM EDT

    Evogene Statistics

    Share Statistics

    Evogene has 6.67M shares outstanding. The number of shares has increased by -89.39% in one year.

    Shares Outstanding

    n/a
    		 6.67M

    Shares Change (YoY)

    n/a
    		 -89.39%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 7.75%

    Shares Floating

    n/a
    		 6.57M

    Failed to Deliver (FTD) Shares

    n/a
    		 78

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 117.9K, so 2.2% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 117.9K

    Short % of Shares Out

    n/a
    		 2.2%

    Short % of Float

    n/a
    		 2.2%

    Short Ratio (days to cover)

    n/a
    		 2.02

    Valuation Ratios

    The PE ratio is -0.65 and the forward PE ratio is -0.92. Evogene's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.65

    Forward PE

    n/a
    		 -0.92

    PS Ratio

    n/a
    		 1.25

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 -7.34

    P/FCF Ratio

    n/a
    		 -0.52

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Evogene.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.15, with a Debt / Equity ratio of -8.87.

    Current Ratio

    n/a
    		 1.15

    Quick Ratio

    n/a
    		 1.06

    Debt / Equity

    n/a
    		 -8.87

    Debt / EBITDA

    n/a
    		 -0.84

    Debt / FCF

    n/a
    		 -0.63

    Interest Coverage

    n/a
    		 -352.54

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $72,743.59

    Profits Per Employee

    n/a
    		 $-140,897.44

    Employee Count

    n/a
    		 117

    Asset Turnover

    n/a
    		 0.21

    Inventory Turnover

    n/a
    		 1.47

    Taxes

    Income Tax

    n/a
    		 9K

    Effective Tax Rate

    n/a
    		 -0.05%

    Stock Price Statistics

    The stock price has increased by -75.97% in the last 52 weeks. The beta is 1.36, so Evogene's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.36

    52-Week Price Change

    n/a
    		 -75.97%

    50-Day Moving Average

    n/a
    		 1.19

    200-Day Moving Average

    n/a
    		 1.73

    Relative Strength Index (RSI)

    n/a
    		 55.72

    Average Volume (20 Days)

    n/a
    		 2,095,055

    Income Statement

    In the last 12 months, Evogene had revenue of 8.51M and earned -16.48M in profits. Earnings per share was -2.89.

    Revenue

    n/a
    		 8.51M

    Gross Profit

    n/a
    		 5.83M

    Operating Income

    n/a
    		 -22.21M

    Net Income

    n/a
    		 -16.48M

    EBITDA

    n/a
    		 -15.38M

    EBIT

    n/a
    		 -17.98M

    Earnings Per Share (EPS)

    n/a
    		 -2.89
    Full Income Statement

    Balance Sheet

    The company has 15.3M in cash and 12.87M in debt, giving a net cash position of 2.43M.

    Cash & Cash Equivalents

    n/a
    		 15.3M

    Total Debt

    n/a
    		 12.87M

    Net Cash

    n/a
    		 2.43M

    Retained Earnings

    n/a
    		 -274.07M

    Total Assets

    n/a
    		 39.86M

    Working Capital

    n/a
    		 2.89M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -19.7M and capital expenditures -626K, giving a free cash flow of -20.33M.

    Operating Cash Flow

    n/a
    		 -19.7M

    Capital Expenditures

    n/a
    		 -626K

    Free Cash Flow

    n/a
    		 -20.33M

    FCF Per Share

    n/a
    		 -3.57
    Full Cash Flow Statement

    Margins

    Gross margin is 68.48%, with operating and profit margins of -260.96% and -193.69%.

    Gross Margin

    n/a
    		 68.48%

    Operating Margin

    n/a
    		 -260.96%

    Pretax Margin

    n/a
    		 -212.02%

    Profit Margin

    n/a
    		 -193.69%

    EBITDA Margin

    n/a
    		 -180.68%

    EBIT Margin

    n/a
    		 -260.96%

    FCF Margin

    n/a
    		 -238.82%

    Dividends & Yields

    EVGN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for EVGN is $3.5, which is 125.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $3.5

    Price Target Difference

    n/a
    		 125.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 25, 2024. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Jul 25, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -10.64

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist